Am J Med

1. KOW CS, Ramachandram DS, Hasan SS, Thiruchelvam K, et al
   Navigating the Shadows: COVID-19's Lingering Threat - Pulmonary Fibrosis.
   Am J Med. 2024;137:e81.
   

   >> Share

   
   

   
   Ann Intern Med

2. WEITZ HH, Merli GJ
   Annals Consult Guys - COVID-19 and Surgery: A Postpandemic Update.
   Ann Intern Med. 2024;177:eW240001.
   

   >> Share

   
   
3. GOTUR D, Mylonakis E
   In adults with post-COVID-19 conditions, a synbiotic preparation, SIM01, alleviated some symptoms at 6 mo.
   Ann Intern Med. 2024 Apr 2. doi: 10.7326/J24-0018.
   

   >> Share

   
   

   
   Antiviral Res

4. KHATUA K, Alugubelli YR, Yang KS, Vulupala VR, et al
   Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors.
   Antiviral Res. 2024;225:105874.
   

   >> Share

   
   
5. SINIAVIN AE, Gushchin VA, Shastina NS, Darnotuk ES, et al
   New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses.
   Antiviral Res. 2024 Mar 28:105871. doi: 10.1016/j.antiviral.2024.105871.
   

   >> Share

   
   
6. PEREZ-VARGAS J, Lemieux G, Thompson CAH, Desilets A, et al
   Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals.
   Antiviral Res. 2024 Mar 26:105869. doi: 10.1016/j.antiviral.2024.105869.
   

   >> Share

   
   
7. MOON C, Porges E, Roberts A, Bacon J, et al
   A combination of nirmatrelvir and ombitasvir boosts inhibition of SARS-CoV-2 replication.
   Antiviral Res. 2024 Mar 14:105859. doi: 10.1016/j.antiviral.2024.105859.
   

   >> Share

   
   
8. WANG W, Wang S, Meng X, Zhao Y, et al
   A virus-like particle candidate vaccine based on CRISPR/Cas9 gene editing technology elicits broad-spectrum protection against SARS-CoV-2.
   Antiviral Res. 2024 Mar 4:105854. doi: 10.1016/j.antiviral.2024.105854.
   

   >> Share

   
   
9. KLEVANSKI M, Kim H, Heilemann M, Kuner T, et al
   Glycan-directed SARS-CoV-2 inhibition by leek extract and lectins with insights into the mode-of-action of Concanavalin A.
   Antiviral Res. 2024 Mar 4:105856. doi: 10.1016/j.antiviral.2024.105856.
   

   >> Share

   
   
10. SCHREIBER A, Rodner F, Oberberg N, Anhlan D, et al
    The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance.
    Antiviral Res. 2024 Mar 2:105840. doi: 10.1016/j.antiviral.2024.105840.
    

    >> Share

    
    

    
    Arch Virol

11. BEDAIR NM, Sakr MA, Mourad A, Eissa N, et al
    Molecular characterization of the whole genome of H9N2 avian influenza virus isolated from Egyptian poultry farms.
    Arch Virol. 2024;169:99.
    

    >> Share

    
    

    
    Biochem Biophys Res Commun

12. KALASHNYK O, Lykhmus O, Sullivan R, Komisarenko S, et al
    Agonists or positive allosteric modulators of alpha7 nicotinic acetylcholine receptor prevent interaction of SARS-Cov-2 receptor-binding domain with astrocytoma cells.
    Biochem Biophys Res Commun. 2024;709:149825.
    

    >> Share

    
    

    
    BMC Pediatr

13. JIANG J, Shen Z, Cao J
    Seizures in febrile children with SARS-CoV-2 infection: clinical features, short-term follow-up.
    BMC Pediatr. 2024;24:257.
    

    >> Share

    
    
14. LIN F, Jiang DJ, Zhang S, Yang Z, et al
    Critically ill children with SARS-COV-2 Omicron infection at a national children medical center, Guangdong, China.
    BMC Pediatr. 2024;24:254.
    

    >> Share

    
    

    
    BMJ

15. MAHASE E
    Covid-19: Charities question inquiry's "refusal" to fully examine mental health impact.
    BMJ. 2024;385:q852.
    

    >> Share

    
    

    
    Cell

16. WAYNE CJ, Blakney AK
    Self-amplifying RNA COVID-19 vaccine.
    Cell. 2024;187:1822-1822.
    

    >> Share

    
    

    
    Drug Saf

17. CAPLANUSI I, Szmigiel A, van der Elst M, Schougaard Christiansen ML, et al
    The Role of the European Medicines Agency in the Safety Monitoring of COVID-19 Vaccines and Future Directions in Enhancing Vaccine Safety Globally.
    Drug Saf. 2024;47:405-418.
    

    >> Share

    
    

    
    J Infect Dis

18. LACOURSE SM, Wetzler EA, Aurelio MC, Escudero JN, et al
    Hybrid immunity to SARS-CoV-2 during pregnancy provides more durable infant antibody responses compared to natural infection or vaccination alone.
    J Infect Dis. 2024 Jan 29:jiae046. doi: 10.1093.
    

    >> Share

    
    
19. HUH K, Kang M, Kim YE, Choi Y, et al
    Risk of Severe COVID-19 and Protective Effectiveness of Vaccination Among Solid Organ Transplant Recipients.
    J Infect Dis. 2023 Dec 14:jiad501. doi: 10.1093.
    

    >> Share

    
    
20. TUTTLE DJ, Castanha PMS, Nasser A, Wilkins MS, et al
    SARS-CoV-2 mRNA vaccines induce greater complement activation and decreased viremia and Nef antibodies in men with HIV-1.
    J Infect Dis. 2023 Nov 30:jiad544. doi: 10.1093.
    

    >> Share

    
    
21. MORI M, Doi T, Murata M, Moriyama Y, et al
    Impact of nutritional status on antibody titer after booster mRNA COVID-19 vaccine among elderly adults in Japan.
    J Infect Dis. 2023 Nov 14:jiad495. doi: 10.1093.
    

    >> Share

    
    
22. ZAMA D, Zanaroli A, Corbelli A, Lo Vecchio A, et al
    SARS-CoV-2 Infection in the Pediatric Oncology Population: The Definitive Comprehensive Report of the Infectious Diseases Working Group of AIEOP.
    J Infect Dis. 2024;229:1050-1058.
    

    >> Share

    
    
23. GUILBAUD R, Franco Yusti AM, Leducq V, Zafilaza K, et al
    Higher Levels of SARS-CoV-2 Genetic Variation in Immunocompromised Patients: A Retrospective Case-Control Study.
    J Infect Dis. 2024;229:1041-1049.
    

    >> Share

    
    
24. ASAMOAH-BOAHENG M, Grunau B, Karim ME, Kirkham TL, et al
    The association of post-COVID-related symptoms and preceding SARS-CoV-2 infection among fully vaccinated paramedics in Canada.
    J Infect Dis. 2023 Oct 31:jiad475. doi: 10.1093.
    

    >> Share

    
    
25. SIMOES EAF, Botteman M, Chirikov V
    Epidemiology of Medically Attended Respiratory Syncytial Virus Lower Respiratory Tract Infection in Japanese Children, 2011-2017.
    J Infect Dis. 2024;229:1112-1122.
    

    >> Share

    
    
26. SARIOL A, Vickers MA, Christensen SM, Weiskopf D, et al
    Monovalent SARS-CoV-2 mRNA vaccine does not boost Omicron-specific immune response in diabetic and control pediatric patients.
    J Infect Dis. 2023 Aug 25:jiad366. doi: 10.1093.
    

    >> Share

    
    

    
    J Virol

27. BOUGON J, Kadijk E, Gallot-Lavallee L, Curtis BA, et al
    Influenza A virus NS1 effector domain is required for PA-X-mediated host shutoff in infected cells.
    J Virol. 2024 Apr 17:e0190123. doi: 10.1128/jvi.01901.
    

    >> Share

    
    
28. MAI F, Bergmann W, Reisinger EC, Muller-Hilke B, et al
    The varying extent of humoral and cellular immune responses to either vector- or RNA-based SARS-CoV-2 vaccines persists for at least 18 months and is independent of infection.
    J Virol. 2024 Mar 19:e0191223. doi: 10.1128/jvi.01912.
    

    >> Share

    
    
29. BABOT M, Boulard Y, Agouda S, Pieri L, et al
    Oligomeric assembly of the C-terminal and transmembrane region of SARS-CoV-2 nsp3.
    J Virol. 2024 Mar 14:e0157523. doi: 10.1128/jvi.01575.
    

    >> Share

    
    
30. ZHENG T, Shen B, Bai Y, Li E, et al
    The PKA-CREB1 axis regulates coronavirus proliferation by viral helicase nsp13 association.
    J Virol. 2024 Mar 6:e0156523. doi: 10.1128/jvi.01565.
    

    >> Share

    
    

    
    JAMA

31. HARRIS E
    COVID-19 Associated With Higher Risk of Autoimmune Diseases.
    JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2092.
    

    >> Share

    
    
32. HARRIS E
    COVID-19 Infection Tied to Slight Cognitive Deficits.
    JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2087.
    

    >> Share

    
    

    
    Lancet

33. WENHAM C, Stout L
    A legal mapping of 48 WHO member states' inclusion of public health emergency of international concern, pandemic, and health emergency terminology within national emergency legislation in responding to health emergencies.
    Lancet. 2024 Mar 22:S0140-6736(24)00156-9. doi: 10.1016/S0140-6736(24)00156.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

34. LIKO J, Cieslak PR
    Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine - Oregon, June 2021-December 2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:317-320.
    

    >> Share

    
    
35. DOSHI RH, Nsasiirwe S, Dahlke M, Atagbaza A, et al
    COVID-19 Vaccination Coverage - World Health Organization African Region, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:307-311.
    

    >> Share

    
    

    
    PLoS One

36. WEISSFLOG M, Kim S, Rajack N, Kolla NJ, et al
    The impact of the COVID-19 pandemic on the use of restraint and seclusion interventions in Ontario emergency departments: A population-based study.
    PLoS One. 2024;19:e0302164.
    

    >> Share

    
    
37. ANDRONESCU LR, Richard SA, Scher AI, Lindholm DA, et al
    SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-up.
    PLoS One. 2024;19:e0297481.
    

    >> Share

    
    
38. HOTEIT R, Bou-Hamad I, Hijazi S, Ayna D, et al
    A cross-sectional study of university students' mental health and lifestyle practices amidst the COVID-19 pandemic.
    PLoS One. 2024;19:e0302265.
    

    >> Share

    
    
39. KYAKUWA N, Kimbugwe G, Nakanjako F, Kalute H, et al
    High uptake of COVID-19 vaccines among healthcare workers in urban Uganda.
    PLoS One. 2024;19:e0277072.
    

    >> Share

    
    
40. HOTH KF, Ten Eyck P, Harland KK, Krishnadasan A, et al
    Availability and use of institutional support programs for emergency department healthcare personnel during the COVID-19 pandemic.
    PLoS One. 2024;19:e0298807.
    

    >> Share

    
    
41. PSZCZOLKOWSKA D, Bojarczuk S, Duszczyk M, Matuszczyk K, et al
    Did Covid-19 make things worse? The pandemic as a push factor stimulating the emigration intentions of junior doctors from Poland: A mixed methods study.
    PLoS One. 2024;19:e0301757.
    

    >> Share

    
    
42. LIN L, Demirhan H, P Johnstone-Robertson S, Lal R, et al
    Assessing the impact of Australia's mass vaccination campaigns over the Delta and Omicron outbreaks.
    PLoS One. 2024;19:e0299844.
    

    >> Share

    
    
43. MOHEBBI A, Eskandarzadeh M, Zangi H, Fatehi M, et al
    In silico study of alkaloids with quercetin nucleus for inhibition of SARS-CoV-2 protease and receptor cell protease.
    PLoS One. 2024;19:e0298201.
    

    >> Share

    
    
44. GOODKIND JR, Van Horn ML, Hess JM, Lardier D, et al
    Protocol of the study: Multilevel community-based mental health intervention to address structural inequities and adverse disparate consequences of COVID-19 pandemic on Latinx Immigrants and African refugees.
    PLoS One. 2024;19:e0298369.
    

    >> Share

    
    
45. PAULOWSKI L, Filip R, Jankovic Makek M, Guglielmetti L, et al
    Impact of the COVID-19 pandemic on the real-world diagnostic infrastructure for tuberculosis-An ESGMYC collaborative study.
    PLoS One. 2024;19:e0291404.
    

    >> Share

    
    
46. KARAHAN D, Bolayir HA, Bolayir A, Demir B, et al
    Can serum interleukin 34 levels be used as an indicator for the prediction and prognosis of COVID-19?
    PLoS One. 2024;19:e0302002.
    

    >> Share

    
    
47. SALAMANCA-BUENTELLO F, Katz R, Silva DS, Upshur REG, et al
    Research ethics review during the COVID-19 pandemic: An international study.
    PLoS One. 2024;19:e0292512.
    

    >> Share

    
    
48. LIM SH, Lim YC, Zaki RA, Johari BM, et al
    Prevalence and predictors of post-acute COVID syndrome among infected healthcare workers at University Malaya Medical Centre.
    PLoS One. 2024;19:e0298376.
    

    >> Share

    
    
49. ABUHAMMAD S, Al-Natour A, Abu Al-Rub S, Hamaideh S, et al
    Intimate partner violence and quality of life among mothers in Jordan during COVID-19 era.
    PLoS One. 2024;19:e0298669.
    

    >> Share

    
    
50. CHOI Y
    Exploring the impact of pandemic fear on visitation to park attractions in urban city: A case study in Seoul, South Korea.
    PLoS One. 2024;19:e0301869.
    

    >> Share

    
    
51. JIANG J, Wang S, Li Y, Wang Y, et al
    Has-miR-199a-3p/RELA/SCD inhibits immune checkpoints in AMD and promotes macrophage-mediated inflammation and pathological angiogenesis through lipid metabolism pathway: A computational analysis.
    PLoS One. 2024;19:e0297849.
    

    >> Share

    
    
52. WIENER RC, Lundstrom EW
    Assessing the COVID-19 pandemic's impact on pediatric baseball and basketball-related craniofacial and neck injuries treated in United States emergency departments, 2003-2022.
    PLoS One. 2024;19:e0302232.
    

    >> Share

    
    
53. JOSE R, Wang W, Sherman G, Rosenthal RN, et al
    Tapping into alcohol use during COVID: Drinking correlates among bartenders and servers.
    PLoS One. 2024;19:e0300932.
    

    >> Share

    
    
54. CHISTY ZA, Li DD, Haile M, Houston H, et al
    Immune response kinetics to SARS-CoV-2 infection and COVID-19 vaccination among nursing home residents-Georgia, October 2020-July 2022.
    PLoS One. 2024;19:e0301367.
    

    >> Share

    
    
55. WANG B, Waris M, Adamiak K, Adnan M, et al
    The effects of the COVID-19 pandemic period on stock market return and volatility. Evidence from the Pakistan Stock Exchange.
    PLoS One. 2024;19:e0295853.
    

    >> Share

    
    
56. MAYOR E, Lieb R
    Dispositional factors in the explanation of symptoms of depression, anxiety, health anxiety and COVID-19 Phobia.
    PLoS One. 2024;19:e0299593.
    

    >> Share

    
    
57. MOON MH, Choi MH
    Association between household income and mental health among adults during the COVID-19 pandemic in Korea: Insights from a community health survey.
    PLoS One. 2024;19:e0289230.
    

    >> Share

    
    
58. ZHANG F, Zhang J, Li M, Jin Z, et al
    Assessing the impact of different contact patterns on disease transmission: Taking COVID-19 as a case.
    PLoS One. 2024;19:e0300884.
    

    >> Share

    
    
59. MILLEST A, Saeed S, Symons C, Carter H, et al
    Effect of face-covering use on adherence to other COVID-19 protective behaviours: A systematic review.
    PLoS One. 2024;19:e0284629.
    

    >> Share

    
    
60. ZHILKOVA A, Alsabahi L, Olson D, Maru D, et al
    Hospital segregation, critical care strain, and inpatient mortality during the COVID-19 pandemic in New York City.
    PLoS One. 2024;19:e0301481.
    

    >> Share

    
    
61. RENEER ZB, Bergeron HC, Reynolds S, Thornhill-Wadolowski E, et al
    mRNA vaccines encoding influenza virus hemagglutinin (HA) elicits immunity in mice from influenza A virus challenge.
    PLoS One. 2024;19:e0297833.
    

    >> Share

    
    
62. ITO MI, Honma Y, Ohnishi T, Watanabe T, et al
    Exogenous and endogenous factors affecting stock market transactions: A Hawkes process analysis of the Tokyo Stock Exchange during the COVID-19 pandemic.
    PLoS One. 2024;19:e0301462.
    

    >> Share

    
    
63. SANVEE-BLEBO LM, Adewuyi PA, Whesseh FK, Babalola OJ, et al
    COVID-19 vaccine hesitancy among adults in Liberia, April-May 2021.
    PLoS One. 2024;19:e0297089.
    

    >> Share

    
    
64. JOHNSTON DB, Coleman HG, Colvin D, Lawther S, et al
    Impact of COVID-19 on acute appendicitis presentation, management and pathology findings in adult and paediatric populations.
    PLoS One. 2024;19:e0300357.
    

    >> Share

    
    
65. CURTIS MG, Wieling E, Bryant C, Campbell RD, et al
    Systemic effects of the COVID pandemic on rural black American men's interpersonal relationships: A phenomenological examination.
    PLoS One. 2024;19:e0297876.
    

    >> Share

    
    
66. KE GN, Gow A, Wong RMM, Raman S, et al
    Perceptions of risk and coping strategies during the COVID-19 pandemic among women and older adults.
    PLoS One. 2024;19:e0301009.
    

    >> Share

    
    
67. LOWHORN RJ, Chowdhury M, Kimitei S, Haskin S, et al
    Comorbidities and their association with COVID-19 mortality in Mexico between January 2020 and August 2021.
    PLoS One. 2024;19:e0296895.
    

    >> Share

    
    
68. PAWLAK K, Malak-Rawlikowska A, Hamulczuk M, Skrzypczyk M, et al
    Has food security in the EU countries worsened during the COVID-19 pandemic? Analysis of physical and economic access to food.
    PLoS One. 2024;19:e0302072.
    

    >> Share

    
    
69. ZAID SNA, Abdul Kadir A, Mohd Noor N, Ahmad B, et al
    Translation and trans-cultural adaptation to the Malay version of the COVID-19 vaccine hesitancy questionnaire among healthcare workers in Malaysia.
    PLoS One. 2024;19:e0302237.
    

    >> Share

    
    
70. LU A, Armstrong M, Alexander R, Vest E, et al
    Trends in pediatric prescription-opioid overdoses in U.S. emergency departments from 2008-2020: An epidemiologic study of pediatric opioid overdose ED visits.
    PLoS One. 2024;19:e0299163.
    

    >> Share

    
    
71. PARMAR J, L'Heureux T, Lobchuk M, Penner J, et al
    Double-duty caregivers enduring COVID-19 pandemic to endemic: "It's just wearing me down".
    PLoS One. 2024;19:e0298584.
    

    >> Share

    
    
72. ZHANG Y, Sui X, Zhang S
    Exploring spatio-temporal impact of COVID-19 on citywide taxi demand: A case study of New York City.
    PLoS One. 2024;19:e0299093.
    

    >> Share

    
    
73. VITORINO C, Canavarro MC, Carona C
    Six-month psychopathological symptom trajectories following the COVID-19 outbreak: Contrasting mental health outcomes between nurses and the general population.
    PLoS One. 2024;19:e0301527.
    

    >> Share

    
    
74. LERDSAMRAN H, Anusorntanawat R, Sangsiriwut K, Sawadpongpan S, et al
    Higher correlation between neutralizing antibodies and surrogate neutralizing or binding antibodies in COVID-19 patients than vaccine recipients.
    PLoS One. 2024;19:e0298033.
    

    >> Share

    
    
75. TAN H, Liu J, Zhang Y
    Effects of COVID-19 vaccine safety framing on parental reactions.
    PLoS One. 2024;19:e0302233.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

76. FREEDMAN AS, Sheen JK, Tsai S, Yao J, et al
    Inferring COVID-19 testing and vaccination behavior from New Jersey testing data.
    Proc Natl Acad Sci U S A. 2024;121:e2314357121.
    

    >> Share

    
    
77. JOHANNESEN N, Tang-Andersen Martinello A, Meyer BB, Vestergaard ET, et al
    Substantial transmission of SARS-CoV-2 through casual contact in retail stores: Evidence from matched administrative microdata on card payments and testing.
    Proc Natl Acad Sci U S A. 2024;121:e2317589121.
    

    >> Share

    
    

    
    Vaccine

78. CONDIE J, Northstone K, Major-Smith D, Halstead I, et al
    Exploring associations between the Big Five personality traits and cognitive ability with COVID-19 vaccination hesitancy and uptake among mothers and offspring in a UK prospective cohort study.
    Vaccine. 2024 Mar 22:S0264-410X(24)00305-0. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
79. MORGAN G, Casalino S, Chowdhary S, Frangione E, et al
    COVID-19 vaccine reactogenicity among participants enrolled in the GENCOV study.
    Vaccine. 2024 Mar 22:S0264-410X(24)00317-7. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
80. HUF SW, Grailey K, Crespo RF, Woldmann L, et al
    Testing the impact of differing behavioural science informed text message content in COVID-19 vaccination invitations on vaccine uptake: A randomised clinical trial.
    Vaccine. 2024 Mar 28:S0264-410X(24)00365-7. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
81. MARTINEZ JL, Lemus N, Lai TY, Mishra M, et al
    The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sex.
    Vaccine. 2024 Apr 15:S0264-410X(24)00451-1. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
82. VAN DER POL S, Zeevat F, Postma MJ, Boersma C, et al
    Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations.
    Vaccine. 2024 Apr 17:S0264-410X(24)00465-1. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
83. WON H, Kim JA, Jeong NY, Choi NK, et al
    Safety of concomitant administration of 23-valent polysaccharide pneumococcal vaccine and influenza vaccine among the elderly.
    Vaccine. 2024 Apr 18:S0264-410X(24)00400-6. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
84. INGRAO F, Ngabirano E, Rauw F, Dauphin G, et al
    Immunogenicity and protective efficacy of a multivalent herpesvirus vectored vaccine against H9N2 low pathogenic avian influenza in chicken.
    Vaccine. 2024 Apr 18:S0264-410X(24)00452-3. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
85. PRICE O, Dietze P, Maher L, Dore GJ, et al
    High COVID-19 vaccine uptake following initial hesitancy among people in Australia who inject drugs.
    Vaccine. 2024 Mar 21:S0264-410X(24)00337-2. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    

    
    Virus Res

86. LIU D, Leung KY, Lam HY, Zhang R, et al
    Interaction and antiviral treatment of coinfection between SARS-CoV-2 and influenza in vitro.
    Virus Res. 2024;345:199371.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share